EQT Accelerates WS Audiology Exit Talks as Copenhagen IPO Option Takes Shape

EQT AB has retained investment banks to evaluate strategic options for WS Audiology, placing a potential initial public offering on the Copenhagen Stock Exchange at the center of deliberations, according to people familiar with the matter. The move signals renewed momentum toward monetizing the Danish hearing-aid maker, which EQT has controlled since acquiring it from Siemens in 2019. The timing of the engagement suggests EQT is actively testing market conditions rather than merely exploring theoretical exits.

WS Audiology ranks among the world's largest hearing-aid manufacturers, competing against Sonova and Demant in a sector shaped by aging demographics and increasing demand for advanced auditory devices. EQT's ownership period has seen the company expand its product portfolio and push for operational improvements, positioning it for a valuation that insiders estimate could reach into the billions of euros. The Copenhagen listing venue carries strategic weight: WS Audiology's Nordic roots and existing investor familiarity with the brand could attract premium valuations and strong institutional interest.

A public offering would represent one of the most significant medtech listings in Europe in recent years, drawing attention from healthcare-focused funds and strategic acquirers who may face fewer regulatory obstacles in a secondary-trading context. However, market volatility, interest-rate sensitivity, and competing private-equity deals in the sector could influence whether EQT proceeds with an IPO or pursues alternative exit routes, including a trade sale or secondary buyout. No final decision has been made, and the scope of the process remains fluid.